Search
for
Sort by
Research 541–570 of 776
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Interleukin-15 is a hair follicle immune privilege guardian
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Stem cell-based therapies for alopecia areata: a narrative review
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Review of Promising Off-Label Use of Deucravacitinib
- Hemp Seed-Derived Exosomes Protect Against Dihydrotestosterone-Induced Chicken Feather Growth Inhibition
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Recent Advances in Drug Development for Hair Loss
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Gynostemma pentaphyllum Hydrodistillate and Its Major Component Damulin B Promote Hair Growth-Inducing Properties In Vivo and In Vitro via the Wnt/β-Catenin Pathway in Dermal Papilla Cells
- An Updated in the Management of Alopecia Areata
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis